Bret Bannerman

Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer

Erik Kupperman, Edmund C. Lee, Yueying Cao et al. · Cancer Research · 2010 · 493 citations

Medicine, Oncology, Pharmacology +13

Antitumor Activity of the Investigational Proteasome Inhibitor MLN9708 in Mouse Models of B-cell and Plasma Cell Malignancies

Edmund C. Lee, Michael Fitzgerald, Bret Bannerman et al. · Clinical Cancer Research · 2011 · 106 citations

Medicine, Oncology, Pharmacology +16

The relationship among tumor architecture, pharmacokinetics, pharmacodynamics, and efficacy of bortezomib in mouse xenograft models

Mark J. Williamson, Matthew D. Silva, Jennifer Terkelsen et al. · Molecular Cancer Therapeutics · 2009 · 61 citations

Medicine, Oncology, Pharmacology +16

Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea

Bret Bannerman, Ling Xu, Matthew D. Jones et al. · Cancer Chemotherapy and Pharmacology · 2011 · 41 citations · Full text

Medicine, Oncology, Pharmacology +16

KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism

Nibedita Chattopadhyay, Allison Berger, Erik Koenig et al. · PLoS ONE · 2015 · 18 citations · Full text

Medicine, Oncology, Pharmacology +13